Recruiting
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
NCT05046613
- Conditions
- Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
- Locations
-
- Evidera, a PPD business unit Wilmington, North Carolina, United States